Executive Sale and Analyst Optimism Create Diverging Views on Vital Farms

A notable divergence has emerged at Vital Farms, where substantial insider selling activity coincides with a wave of bullish analyst upgrades. This contrast presents investors with a compelling puzzle: is the leadership’s action a signal of internal concern, or merely a routine portfolio adjustment, while external experts see significant upside?

The immediate catalyst for renewed Wall Street interest was the company’s impressive second-quarter 2025 earnings report, which substantially exceeded market expectations. This prompted no fewer than four major financial institutions to significantly raise their price targets.

• TD Cowen reaffirmed its “Buy” recommendation while increasing its target to $48 from $42.
• DA Davidson set a $52 target, pointing to the company’s enhanced supply Read more...